Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Insoo Bae

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|February 9, 2008
BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhRHyo Jin Kang, Hee Jeong Kim, Chi-Heum Cho, et al.
International Journal of Oncology|May 9, 2015
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6Yong Weon Yi, Kyusic You, Edward Jeong Bae, et al.
The Journal of Toxicological Sciences|May 14, 2013
Correlations between BRCA1 defect and environmental factors in the risk of breast cancerHyo Jin Kang, Young Bin Hong, Yong Weon Yi, et al.
Molecular Carcinogenesis|April 11, 2012
Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cellsYong Weon Yi, Hyo Jin Kang, Hee Jeong Kim, et al.
Experimental & Molecular Medicine|February 28, 2015
β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cellsYong Weon Yi, Hyo Jin Kang, Edward Jeong Bae, et al.
Oncotarget|July 13, 2013
Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cellsYong Weon Yi, Hyo Jin Kang, Hee Jeong Kim, et al.
International Journal of Oncology|June 20, 2012
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
Journal of Korean Medical Science|April 13, 2013
The synergistic apoptotic interaction of Indole-3-Carbinol and Genistein with TRAIL on endometrial cancer cellsBidur Parajuli, So-Jin Shin, Sang-Hoon Kwon, et al.
Oncotarget|November 16, 2017
Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumorHyo Jin Kang, Yong Weon Yi, Shu-Jie Hou, et al.
Journal of Korean Medical Science|August 30, 2008
Cyclin-dependent kinase inhibitor p27Kip1 controls growth and cell cycle progression in human uterine leiomyomaSabarish Ramachandran, Kun-Young Kwon, So-Jin Shin, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|February 9, 2008
BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhRHyo Jin Kang, Hee Jeong Kim, Chi-Heum Cho, et al.
International Journal of Oncology|May 9, 2015
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6Yong Weon Yi, Kyusic You, Edward Jeong Bae, et al.
The Journal of Toxicological Sciences|May 14, 2013
Correlations between BRCA1 defect and environmental factors in the risk of breast cancerHyo Jin Kang, Young Bin Hong, Yong Weon Yi, et al.
Molecular Carcinogenesis|April 11, 2012
Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cellsYong Weon Yi, Hyo Jin Kang, Hee Jeong Kim, et al.
Experimental & Molecular Medicine|February 28, 2015
β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cellsYong Weon Yi, Hyo Jin Kang, Edward Jeong Bae, et al.
Oncotarget|July 13, 2013
Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cellsYong Weon Yi, Hyo Jin Kang, Hee Jeong Kim, et al.
International Journal of Oncology|June 20, 2012
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
Journal of Korean Medical Science|April 13, 2013
The synergistic apoptotic interaction of Indole-3-Carbinol and Genistein with TRAIL on endometrial cancer cellsBidur Parajuli, So-Jin Shin, Sang-Hoon Kwon, et al.
Oncotarget|November 16, 2017
Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumorHyo Jin Kang, Yong Weon Yi, Shu-Jie Hou, et al.
Journal of Korean Medical Science|August 30, 2008
Cyclin-dependent kinase inhibitor p27Kip1 controls growth and cell cycle progression in human uterine leiomyomaSabarish Ramachandran, Kun-Young Kwon, So-Jin Shin, et al.
Pageof 5